USANA's CEO Myron W. Wentz, Ph.D. Has Been Elected to Serve on Immunosyn Corporation's Board of Directors

CNN Money

Immunosyn Corporation is pleased to announce that Myron W. Wentz, Ph.D., Chief Executive Officer and Chairman of the Board of USANA Health Sciences, Incorporated , was elected to serve as a member of its Board of Directors. Dr. Wentz will be filling a newly created director position resulting from the increase in the authorized number of directors of Immunosyn.

"To add to our Board of Directors a Ph.D. in microbiology and immunology, and an internationally recognized pioneer in human cell culture technology and infectious disease diagnoses such as Dr. Wentz with his longstanding successful business history in our industry, is a significant and synergistic addition to the leadership of Immunosyn," stated Stephen D. Ferrone, President and CEO of Immunosyn. "Because Dr. Wentz is a scientist as well as a highly accomplished businessman, he understands the significance of SF-1019 from a scientific, humanitarian and business perspective. His industry background, knowledge, network, advice and good counsel will be a substantial benefit to Immunosyn and its shareholders."

Dr. Wentz founded USANA in 1992 and has been the CEO and Chairman since its inception. USANA is a public company that develops and manufactures high quality nutritional and personal care products that are sold directly to Preferred Customers and Associates throughout the world. The success of USANA's products is largely the result of Dr. Wentz's insights on cellular nutrition.

Powered by ScribeFire.